Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.
W J Kovacs, … , B R Carlson, J D Wilson
W J Kovacs, … , B R Carlson, J D Wilson
Published April 1, 1984
Citation Information: J Clin Invest. 1984;73(4):1095-1104. https://doi.org/10.1172/JCI111295.
View: Text | PDF
Research Article Article has an altmetric score of 6

A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.

  • Text
  • PDF
Abstract

Dihydrotestosterone-receptor complexes formed in human fibroblast cytosol prepared at 0 degrees C in the presence of sodium molybdate can be readily transformed to the DNA-binding state by heating at 25 degrees C. Under these conditions 50-70% of dihydrotestosterone-receptor complexes bind to DNA. We describe here studies of the transformation process in cytosols derived from normal cells and from fibroblasts propagated from subjects with syndromes of androgen resistance. In contrast to the situation with dihydrotestosterone, normal testosterone-receptor complexes are unstable under in vitro transforming conditions. Although equal amounts of hormone-receptor complex are formed at 0 degrees C, only 15% of testosterone-receptor complexes remain stable and acquire DNA-binding capacity after warming. This instability is not reversible upon lowering the temperature and is corrected by low concentrations (0.25 microM) of the protease inhibitor leupeptin. We have also identified two cousins with androgen resistance whose androgen-receptor complexes exhibit similar in vitro transformation lability with both dihydrotestosterone and testosterone. Phenotypic evidence in these subjects indicates that dihydrotestosterone-mediated processes are more completely impaired than are testosterone-mediated events. These findings suggest that dihydrotestosterone may amplify the androgenic signal at its targets not only by its higher affinity for the receptor but also by its more efficient conversion to the DNA-binding state and that such amplification may be less critical in target tissues in which testosterone suffices for androgenic effect. This offers one possible explanation of how a mutation that affects a single receptor protein may differentially impair the actions of two binding ligands of the receptor.

Authors

W J Kovacs, J E Griffin, D D Weaver, B R Carlson, J D Wilson

×

Total citations by year

Year: 2024 2021 2019 2018 2017 2013 2011 2010 2009 2005 2004 2003 2002 2001 2000 1999 1998 1996 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1970 Total
Citations: 1 1 2 1 1 1 2 1 1 2 1 1 2 1 2 2 5 1 3 2 2 1 4 7 4 2 5 3 1 1 63
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (63)

Title and authors Publication Year
Improvement of Late-Onset Hypogonadism Symptoms of Fermented Morinda citrifolia Extract in TM3 Leydig and TM4 Sertoli Cells
Kwon HY, Lee H, Choi JS, Lim SH, Kim T, Bae K, Jang YA, Lee JY, Choung SY, Min DS
Nutrients 2024
Inhibitory Activities of Dimeric Ellagitannins Isolated from Cornus alba on Benign Prostatic Hypertrophy
DH Park, KH Park, J Yin, MJ Kim, SE Yoon, SH Lee, JH Heo, HJ Chung, JW Kim, KM Kim, MW Lee
Molecules (Basel, Switzerland) 2021
Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
L Zhu, J Zhou, Y Pan, J Lv, Y Liu, S Yu, Y Zhang
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2019
The Chalice Sign: Characteristic Morphology of the Cervical Carotid Bifurcation in Patients with Loeys-Dietz Syndrome
JC Benson, W Brinjikji
Clinical Neuroradiology 2019
Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
LJ Mosher, SC Godar, M Morissette, KM McFarlin, S Scheggi, C Gambarana, SC Fowler, TD Paolo, M Bortolato
Psychoneuroendocrinology 2018
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
RS Swerdloff, RE Dudley, ST Page, C Wang, WA Salameh
Endocrine reviews 2017
Current status of 5α-reductase inhibitors in prostate disease management
DI Kang, JI Chung
Korean Journal of Urology 2013
Reduced Bone Mass and Muscle Strength in Male 5α-Reductase Type 1 Inactivated Mice
SH Windahl, N Andersson, AE Börjesson, C Swanson, J Svensson, S Movérare-Skrtic, K Sjögren, R Shao, MK Lagerquist, C Ohlsson, JM Vanacker
PloS one 2011
Harper's Textbook of Pediatric Dermatology
HM Goodyear
Harper's Textbook of Pediatric Dermatology 2011
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Hormones, Brain and Behavior
J Bernal
Hormones, Brain and Behavior 2009
Molecular Basis of Steroid Action in the Prostate
YS Zhu
Cellscience 2005
5α-Reductase Isozymes in the Prostate
YS Zhu, GH Sun
Journal of medical sciences (Taipei, Taiwan) 2005
Fetal hormones and sexual differentiation
V Sobel, YS Zhu, J Imperato-McGinley
Obstetrics and Gynecology Clinics of North America 2004
Androgens in Health and Disease
CJ Bagatell, WJ Bremner
2003
Androgens and male physiology the syndrome of 5α-reductase-2 deficiency
J Imperato-McGinley, YS Zhu
Molecular and Cellular Endocrinology 2002
Discovery of Potent, Nonsteroidal, and Highly Selective Glucocorticoid Receptor Antagonists
BP Morgan, AG Swick, DM Hargrove, JA LaFlamme, MS Moynihan, RS Carroll, KA Martin, E Lee, D Decosta, J Bordner
Journal of Medicinal Chemistry 2002
Unexpected Virilization in Male Mice Lacking Steroid 5α-Reductase Enzymes
MS Mahendroo, KM Cala, DL Hess, DW Russell
Endocrinology 2001
Expression of type 1 5alpha-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthicR): a new model for screening skin-targeted androgen modulators
FX Bernard, C Barrault, A Deguercy, B Wever, M Rosdy
International Journal of Cosmetic Science 2000
Expression of type 1 5α-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic®): a new model for screening skin-targeted androgen modulators
FX Bernard, C Barrault, A Deguercy, B Wever, M Rosdy
International Journal of Cosmetic Science 2000
Androgen-activating enzymes in the central nervous systemProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998
A Poletti, L Martini
The Journal of Steroid Biochemistry and Molecular Biology 1999
Neurosteroids
EE Baulieu, P Robel, M Schumacher
1999
Insulin-Like Growth Factor-I and -II in Human Benign Prostatic Hyperplasia: Relationship with Binding Proteins 2 and 3 and Androgens
S Monti, FD Silverio, S Lanzara, P Varasano, C Martini, C Tosti-Croce, F Sciarra
Steroids 1998
5α-Reductase Isozymes in the Central Nervous System
A Poletti, A Coscarella, P Negri-Cesi, A Colciago, F Celotti, L Martini
Steroids 1998
Endocrine and adrenergic pharmacological intervention in diseases of the prostate
A Rane
British Journal of Clinical Pharmacology 1998
Natural potent androgens: Lessons from human genetic models
Y Zhu, MD Katz, J Imperato-McGinley
Baillière's Clinical Endocrinology and Metabolism 1998
Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
W Chen, CC Zouboulis, M Fritsch, U Blume-Peytavi, V Kodelja, S Goerdt, V Luu-The, CE Orfanos
Journal of Investigative Dermatology 1998
Metabolism of steroids in the brain: a new insight into the role of 5α-reductase and aromatase in brain differentiation and functions
P Negri-Cesi, A Poletti, F Celotti
The Journal of Steroid Biochemistry and Molecular Biology 1996
9 Role of 5α-reductase in health and disease
VA Randall
Baillière's Clinical Endocrinology and Metabolism 1994
The potential for hormonal prevention trials
LG Ford, OW Brawley, JA Perlman, SG Nayfield, KA Johnson, BS Kramer
Cancer 1994
Hypogonadism
S Plymate
Endocrinology and metabolism clinics of North America 1994
The androgen resistance syndromes: Clinical and biochemical aspects
HU Schweikert
European Journal of Pediatrics 1993
Local implants of testosterone metabolites regulate vasopressin mRNA in sexually dimorphic nuclei of the rat brain
MD Brot, GJ Vries, DM Dorsa
Peptides 1993
Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene
MJ McPhaul, M Marcelli, S Zoppi, CM Wilson, JE Griffin, JD Wilson
Journal of Clinical Investigation 1992
5 Control of spermatogenesis by follicle stimulating hormone and testosterone
DM Kretser, RI McLachlan, DM Robertson, NG Wreford
Baillière's Clinical Endocrinology and Metabolism 1992
Role of 5α-Reductase Inhibitors in the Treatment of Advanced Prostatic Carcinoma
GJ Gormley
The Urologic clinics of North America 1991
Androgen resistance due to decreased amounts of androgen receptor: A reinvestigation
PB Grino, JE Griffin, JD Wilson
Journal of Steroid Biochemistry 1990
The state transitions of normal and mutant androgen-receptor complexes in human genital skin fibroblasts
M Kaufman, L Pinsky, B Gottlieb, M Trifiro
Journal of Steroid Biochemistry 1990
Determination of the affinity of a steroid for its receptor is not sufficient to measure its intrinsic hormonal activity
FJ Zeelen
Steroids 1990
Advances in Human Genetics
H Harris, K Hirschhorn
1990
Intracellular and nuclear binding of [3H]dihydrotestosterone in cultured genital skin fibroblasts of patients with severe hypospadias
HU Schweikert, M Schlüter, G Romalo
Journal of Clinical Investigation 1989
Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acne
BW Metcalf, MA Levy, DA Holt
Trends in Pharmacological Sciences 1989
Characterization and expression of a cDNA encoding the human androgen receptor
WD Tilley, M Marcelli, JD Wilson, MJ McPhaul
Proceedings of the National Academy of Sciences 1989
A CONVENIENT “HYDROGEN TRANSFER” HYDROGENATION OF TESTOSTERONE
DM Spyriounis, G Ikonomidis, VJ Demopoulos
Organic Preparations and Procedures International 1989
Partial purification and characterisation of the human skin fibroblast androgen receptor: Detection of abnormal receptor complexes in cells from patients with androgen insensitivity syndromes
IJ McEwan, DA Rowney, MB Hodgins
Journal of Steroid Biochemistry 1989
A single-site allosteric model of intracellular androgen-receptor interaction
M Kaufman, L Pinsky
Journal of Steroid Biochemistry 1989
Androgen receptors: Structures, mutations, antibodies and cellular dynamics
S Liao, J Kokontis, T Sai, RA Hiipakka
Journal of Steroid Biochemistry 1989
High efficiency covalent radiolabeling of the human androgen receptor. Studies in cultured fibroblasts using dihydrotestosterone 17 beta-bromoacetate
WJ Kovacs, MK Turney
Journal of Clinical Investigation 1988
THE FIBROBLAST AS A MODEL FOR ANDROGEN RESISTANT STATES
IA Hughes, BA Evans
Clinical Endocrinology 1988
Steroid Receptors in Health and Disease
VK Moudgil
1988
Cloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome
DB Lubahn, DR Joseph, PM Sullivan, HF Willard, FS French, EM Wilson
Science 1988
Syndromes of Androgen Resistance
JE Griffin, JD Wilson
Hospital Practice 1987
Hormone Resistance and Other Endocrine Paradoxes
MP Cohen, PP Foà
1987
Inherited 5α-reductase deficiency in man
J Imperato-McGinley, T Gautier
Trends in Genetics 1986
Ligand-specific thermal misbehavior of synthetic androgen-receptor complexes in genital skin fibroblasts of subjects with familial ligand-sensitive androgen resistance
M Kaufman, L Pinsky, DW Killinger
Journal of Steroid Biochemistry 1986
The Receptors
RG Rosenfeld, RL Hintz
The Receptors 1986
Steroid Hormone Resistance
GP Chrousos, DL Loriaux, MB Lipsett
1986
Steroid Hormone Resistance: Mechanisms and Clinical Aspects
GP Chrousos, DL Loriaux, MB Lipsett
1986
Mutations that impair androgen action
JD Wilson, JE Griffin
Trends in Genetics 1985
AUGMENTATION OF ANDROGEN-RECEPTOR BINDING IN VITRO: STUDIES IN NORMALS AND PATIENTS WITH ANDROGEN INSENSITIVITY
BA Evans, IA Hughes
Clinical Endocrinology 1985
Whole Cell and Nuclear Androgen Uptake in Skin Fibroblasts from Infertile Men
C Eil, GT Gamblin, JW Hodge, RV Clark, RJ Sherins
Journal of andrology 1985
Endocrine and genetic characterization of cousins with male pseudohermaphroditism: evidence that the Lubs pheno-type can result from a mutation that alters the structure of the androgen receptor
JD Wilson, BR Carlson, DD Weaver, WJ Kovacs, JE Griffin
Clinical Genetics 1984
Testosterone
DW Killinger
Canadian Medical Association journal 1970

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 1 Wikipedia pages
9 readers on Mendeley
See more details